Axsome Therapeutics, Inc. (LON:0HKF)

Axsome Therapeutics Statistics

Total Valuation

LON:0HKF has a market cap or net worth of GBP 3.86 billion. The enterprise value is 3.80 billion.

Market Cap	3.86B
Enterprise Value	3.80B

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	49.90M
Shares Outstanding	n/a
Shares Change (YoY)	+2.92%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.69
PB Ratio	72.40
P/TBV Ratio	305.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.07
EV / Sales	10.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-42.96

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.97.

Current Ratio	1.57
Quick Ratio	1.47
Debt / Equity	2.97
Debt / EBITDA	n/a
Debt / FCF	-1.79
Interest Coverage	-24.62

Financial Efficiency

Return on equity (ROE) is -280.68% and return on invested capital (ROIC) is -44.47%.

Return on Equity (ROE)	-280.68%
Return on Assets (ROA)	-21.90%
Return on Invested Capital (ROIC)	-44.47%
Return on Capital Employed (ROCE)	-69.92%
Revenue Per Employee	427,098
Profits Per Employee	-213,017
Employee Count	683
Asset Turnover	0.83
Inventory Turnover	2.51

Taxes

Income Tax	-638,663
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.68%
50-Day Moving Average	106.01
200-Day Moving Average	104.85
Relative Strength Index (RSI)	47.11
Average Volume (20 Days)	1,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.49

Income Statement

In the last 12 months, LON:0HKF had revenue of GBP 361.32 million and -180.21 million in losses. Loss per share was -3.70.

Revenue	361.32M
Gross Profit	330.53M
Operating Income	-151.93M
Pretax Income	-180.85M
Net Income	-180.21M
EBITDA	-145.72M
EBIT	-151.93M
Loss Per Share	-3.70

Balance Sheet

The company has 221.17 million in cash and 158.61 million in debt, giving a net cash position of 62.56 million.

Cash & Cash Equivalents	221.17M
Total Debt	158.61M
Net Cash	62.56M
Net Cash Per Share	n/a
Equity (Book Value)	53.34M
Book Value Per Share	1.07
Working Capital	141.98M

Cash Flow

In the last 12 months, operating cash flow was -88.05 million and capital expenditures -343,783, giving a free cash flow of -88.39 million.

Operating Cash Flow	-88.05M
Capital Expenditures	-343,783
Free Cash Flow	-88.39M
FCF Per Share	n/a

Margins

Gross margin is 91.48%, with operating and profit margins of -42.05% and -49.88%.

Gross Margin	91.48%
Operating Margin	-42.05%
Pretax Margin	-50.05%
Profit Margin	-49.88%
EBITDA Margin	-40.33%
EBIT Margin	-42.05%
FCF Margin	n/a

Dividends & Yields

LON:0HKF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.92%
Shareholder Yield	n/a
Earnings Yield	-4.67%
FCF Yield	-2.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HKF has an Altman Z-Score of 2.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	4